Xenetic Biosciences, Inc. (XBIO)
NASDAQ·Healthcare·Biotechnology
$3.13
+3.30%
Mkt Cap $3.56M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $690.00K | $766.30K | +11.06% | -$0.52 | -$0.22 | +57.69% | — | — |
| Q4 2025 Nov 12, 2025 | $630.00K | $1.03M | +63.01% | -$0.49 | -$0.33 | +32.65% | — | — |
| Q3 2025 Aug 12, 2025 | $479.00K | $589.90K | +23.15% | -$0.64 | -$0.45 | +29.69% | — | — |
| Q2 2025 May 13, 2025 | $516.00K | $593.26K | +14.97% | -$0.72 | -$0.59 | +18.06% | — | — |
| Q4 2024 Nov 12, 2024 | $750.00K | $614.24K | -18.10% | -$0.14 | -$0.28 | -100.00% | — | — |
| Q3 2024 Aug 13, 2024 | $540.00K | $726.40K | +34.52% | -$0.83 | -$0.83 | +0.00% | — | — |
| Q2 2024 May 9, 2024 | $650.00K | $510.82K | -21.41% | -$0.79 | -$0.78 | +1.27% | — | — |
| Q1 2024 Mar 21, 2024 | $680.00K | $671.96K | -1.18% | -$0.87 | -$0.77 | +11.49% | — | — |
| Q4 2023 Nov 10, 2023 | $680.00K | $611.17K | -10.12% | -$1.12 | -$0.69 | +38.39% | — | — |
| Q3 2023 Aug 11, 2023 | $440.00K | $651.00K | +47.96% | -$1.13 | -$0.69 | +38.94% | — | — |
| Q2 2023 May 11, 2023 | $410.00K | $605.84K | +47.77% | -$1.10 | -$0.60 | +45.45% | — | — |
| Q1 2023 Mar 23, 2023 | $490.00K | $486.97K | -0.62% | -$0.09 | -$1.00 | -1011.11% | — | — |
| Q4 2022 Nov 10, 2022 | $410.00K | $414.25K | +1.04% | -$1.80 | -$0.60 | +66.67% | — | — |
| Q3 2022 Aug 12, 2022 | $420.00K | $416.71K | -0.78% | -$1.20 | -$1.90 | -58.33% | — | — |
| Q2 2022 May 12, 2022 | $200.00K | $388.99K | +94.50% | -$1.10 | -$1.20 | -9.09% | — | — |
| Q1 2022 Mar 22, 2022 | $100.00K | $332.60K | +232.60% | -$1.50 | -$1.80 | -20.13% | — | — |
| Q4 2021 Nov 12, 2021 | $320.16K | $349.27K | +9.09% | -$1.20 | -$1.30 | -8.33% | — | — |
| Q3 2021 Aug 12, 2021 | $190.00K | $287.60K | +51.37% | -$1.60 | -$1.30 | +18.75% | — | — |
| Q2 2021 May 12, 2021 | $161.80K | $191.22K | +18.18% | -$1.30 | -$1.50 | -15.38% | — | — |
| Q1 2021 Mar 16, 2021 | — | $151.33K | — | -$0.20 | -$0.16 | +20.00% | — | — |